These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 2106691

  • 1. Strategies to promote hemostasis in patients with F VIII inhibitors.
    Lusher JM.
    Prog Clin Biol Res; 1990; 324():39-46. PubMed ID: 2106691
    [No Abstract] [Full Text] [Related]

  • 2. [Outcome of hemorrhage treatment in children with hemophilia A related to factor VIII inhibitor].
    Klukowska A, Zieleniewska B.
    Acta Haematol Pol; 1994; 25(4):349-54. PubMed ID: 7847036
    [Abstract] [Full Text] [Related]

  • 3. New alternatives and strategies in the treatment of inhibitors.
    Hoyer LW.
    Prog Clin Biol Res; 1984; 150():367-72. PubMed ID: 6431440
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Clinical issues in inhibitors.
    Astermark J, Santagostino E, Keith Hoots W.
    Haemophilia; 2010 Jul; 16 Suppl 5():54-60. PubMed ID: 20590857
    [Abstract] [Full Text] [Related]

  • 6. [Successful induction of immune tolerance and novel hemostatic effects in a hemophilia A with high-responder inhibitor by regular infusions of factor VIII].
    Shima M, Sawamoto Y, Kamisue M, Shibata Y, Tuzi S, Kuwabara M, Tanaka I, Tanizawa T, Tanaka A, Ueda M, Kakishita E, Yoshioka A.
    Rinsho Ketsueki; 1996 Nov; 37(11):1303-8. PubMed ID: 8960666
    [Abstract] [Full Text] [Related]

  • 7. Factor VIII inhibitors in haemophilia.
    Lancet; 1983 Apr 02; 1(8327):742-3. PubMed ID: 6132087
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Inhibitors of factor VIII: detection and treatment.
    Brettler DB.
    Southeast Asian J Trop Med Public Health; 1993 Apr 02; 24 Suppl 1():21-5. PubMed ID: 7886576
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The management of musculoskeletal problems in hemophilia. Part I. Principles of medical management of hemophilia.
    McMillan CW, Greene WB, Blatt PM, White GC, Roberts HR.
    Instr Course Lect; 1983 Apr 02; 32():210-6. PubMed ID: 6443730
    [Abstract] [Full Text] [Related]

  • 12. The physiologic basis for therapy of classic hemophilia (factor 8 deficiency) and related disorders. Combined clinical staff conference at the National Institutes of Health.
    Ann Intern Med; 1967 Oct 02; 67(4):856-82. PubMed ID: 5299081
    [No Abstract] [Full Text] [Related]

  • 13. [Advances in the field of hemophilia therapy].
    Loeliger EA, Veltkamp JJ.
    Ned Tijdschr Geneeskd; 1968 Sep 07; 112(36):1593-5. PubMed ID: 5680135
    [No Abstract] [Full Text] [Related]

  • 14. [Present possibilities in the treatment of hemophilia with the available inhibitors].
    Haracić M, Kamhi J, Kurto J.
    Med Arh; 1983 Sep 07; 37(4):175-80. PubMed ID: 6443876
    [No Abstract] [Full Text] [Related]

  • 15. Surgery in haemophilic patients with inhibitors.
    Rodriguez-Merchan EC.
    Haemophilia; 2004 Sep 07; 10 Suppl 2():1-2. PubMed ID: 15385039
    [No Abstract] [Full Text] [Related]

  • 16. [Acquired hemophilia: current status in Japan and immuno-biochemical features of autoantibodies to factor VIII].
    Tanaka I, Shima N.
    Rinsho Ketsueki; 2005 Feb 07; 46(2):91-8. PubMed ID: 16447701
    [No Abstract] [Full Text] [Related]

  • 17. Factors affecting choice of hemostatic agent for the hemophilia patient with an inhibitor antibody.
    Monahan PE, Aledort LM, Hemophilia Inhibitor Study Group.
    Am J Hematol; 2004 Dec 07; 77(4):346-50. PubMed ID: 15558804
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.